Meg G. Takezawa

Meg G. Takezawa

Auto-generated profile, based on publicly available information

Meg G. Takezawa

University of Washington

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 July 2025 in Journal of Biological Chemistry
Verified
Journal Article
Open access
BHBrad C. Hansen
Brad C. Hansen
CAChristopher M. Arian
Christopher M. Arian
YZYuting Zeng
Yuting Zeng
MTMeg G. Takezawa
Meg G. Takezawa
ATAshleigh B. Theberge
Ashleigh B. Theberge
EKEdward Kelly
Edward Kelly
Accelerating development of complex in vitro models (CIVMs) drives a need for additional methods to characterize these systems for use in toxicology and drug development. Relative to traditional cell culture, CIVMs can use a lower number of cells, are cultured for longer periods of time, and typically involve engineered 3-D cell organization. Standard single-cell assessment tools are not conducive to these types of complex models due to cell isolation stress, cell loss, and high cost. In this report, we benchmark RNA-seq deconvolution, which utilizes publicly available scRNA-seq datasets to predict cell proportions from bulk RNA-seq data derived from two CIVMs: a stem-cell-based human intestinal organoid CIVM and a neonatal rodent testis CIVM. We consider the impact of multiple imputation methods for scRNA-seq to restore the gene distribution of the original tissue and benchmark multiple deconvolution methods. The accuracy of deconvolution methods varied significantly in our analyses but provided valuable information on the emergence of an enterocyte cell population from the LGR5+ crypt stem cells following differentiation in the intestinal organoid CIVM. In the testis CIVM, deconvolution indicated that a small population of germ cells were retained over time, peritubular myoid cells proliferated over time, and that Leydig cell estimates remained stable with physiologically relevant hormone stimulation. In our analysis, using imputed single-cell references improved deconvolution accuracy. Deconvolution can be a useful tool for novel CIVM characterization, especially with rapidly growing libraries of single-cell data across tissues and developmental time.

14 January 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
WTWan-Chen Tu
Wan-Chen Tu
AMAnika M. McManamen
Anika M. McManamen
XSXiaojing Su
Xiaojing Su
IJIngrid Jeacopello
Ingrid Jeacopello
MTMeg G. Takezawa
Meg G. Takezawa
ATAshleigh B. Theberge
Ashleigh B. Theberge
Respiratory infections are common in children, and there is a need for user-friendly collection methods. Here, we performed the first human subjects study using the CandyCollect device, a lollipop inspired saliva collection device. 1 We showed the CandyCollect device can be used to collect salivary bacteria from healthy adults using Streptococcus mutans and Staphylococcus aureus as proof-of-concept commensal bacteria. We enrolled healthy adults in a nationwide (USA) remote study in which participants were sent study packages containing CandyCollect devices and traditional commercially available oral swabs and spit tubes. Participants sampled themselves at home, completed usability and user preference surveys, and mailed the samples back to our laboratory for analysis by qPCR. Our results showed that for participants in which a given bacterium ( S. mutans or S. aureus ) was detected in one or both of the commercially available methods (oral swab and/or spit tubes), CandyCollect devices had a 100% concordance with the positive result (n=14 participants). Furthermore, the CandyCollect device was ranked the highest preference sampling method among the three sampling methods by 26 participants surveyed (combining survey results across two enrollment groups). We also showed that the CandyCollect device has a shelf life of up to 1 year at room temperature, a storage period that is convenient for clinics or patients to keep the CandyCollect device and use it any time. Taken together, we have demonstrated that the CandyCollect is a user-friendly saliva collection tool that has the potential to be incorporated into diagnostic assays in clinic visits and telemedicine. For Table of Contents Only:

6 February 2026 in medRxiv
Verified
Preprint
Open access
FSFilip Stefanovic
Filip Stefanovic
IRIngrid Robertson
Ingrid Robertson
KMKathleen Moloney
Kathleen Moloney
JEJane Edelson
Jane Edelson
SNSerena Nguyen
Serena Nguyen
ATAshleigh B Theberge
Ashleigh B Theberge
Structured Abstract Importance: Remote sampling technologies are invaluable for protecting both participants and researchers when studying highly infectious diseases. When leveraged for longitudinal studies, remote sampling with transcriptomic readouts is a powerful tool for studying the host immune response. Additionally, remote study flexibility circumvents common barriers to research participation including length of commute, transportation, and scheduling, thereby expanding access to clinical research. Objective: In this work, we investigate the effectiveness of a remote study model for reaching women from underrepresented, underserved, and underreported (U3) populations. We sought to recruit individuals who qualify as underrepresented in clinical research, who are located in rural areas, or who come from disadvantaged backgrounds per the NIH definition. Design: In this longitudinal study, U3 women positive for COVID-19 were enrolled and followed over the course of 6 months. In the first month of the infection, participants (n = 40) self-collected a set of 5 nasal swabs, 5 homeRNA-stabilized blood samples, and 2 additional unstabilized blood samples at first and last sampling. Sampling time points were spaced 5 days apart, so that the total of the 5 time points was completed within 25 days. homeRNA is a platform for remote self-collection of blood samples with subsequent RNA stabilization. A subset of participants likely to develop post-acute sequelae of COVID-19 (PASC) and their age-matched controls were selected to self-collect an additional set of 5 nasal swabs and 5 homeRNA-stabilized blood samples during month 3 of study participation, with the same sampling frequency. All participants were resurveyed at months 4, 5, and 6 about their symptoms. Participants also completed surveys at each sampling and a more comprehensive survey about study experience after each set of 5 time points. Setting: This was a fully remote study with all sampling supplies and instructions shipped to the participants. Participants self-collected blood and nasal swabs at home and shipped these back to our lab for further processing. Surveys were administered electronically using REDCap. Participants: For this study, we enrolled women who were 18 or older, met the NIH criteria for U3, and who had tested positive for SARS-CoV-2 within a week of enrollment. Further, we excluded protected populations including individuals who were pregnant and/or incarcerated. Of the 334 individuals who completed the screening process, 65 were invited into the study based on the eligibility criteria and balancing age, race/ethnicity, and state of residence to closely correspond to the demographics of the United States. Of the 65 invited individuals, 40 were fully enrolled in the study and 39 completed all study components. Main Outcomes and Measures: Prior to the study, we proposed that the increased flexibility of a remote study design would allow for participation of populations underrepresented in clinical research. The primary measurements planned for this study consisted of usability data and general experience in a longitudinal study. These data were collected by self report using electronically administered surveys. The Consolidated Framework for Implementation Research (CFIR), a well-established implementation science framework, was used to guide the development of questions about usability and study experience. Results: 40 women were recruited from 19 states, with diverse racial backgrounds (62% White, 15% Black or African American, 10% Asian, 5% American Indian or Alaska Native, 5% Other, 3% More than one race), a mostly even age distribution (26% ages 20 - 29, 15% ages 30 - 39, 31% ages 40 - 49, 28% ages 50+), and most of whom (80%) are categorized as having a disadvantaged background per the NIH. Survey responses show high satisfaction with the study, where all participants who completed the study (100%, n = 39/39) indicating that they would be willing to participate in a similar study again, with most (n = 32/39) indicating a willingness to participate for up to 4 years with around 15 samples collected per year. We note that 4 years was the longest time period that participants were able to select in their surveys, suggesting that participants may be willing to participate for even longer periods. Most (>90%) either agreed or strongly agreed that all components of the kit were easy to use. Conclusions and Relevance: The high retention (98%, n = 39/40) and satisfaction of participants in this study indicates the utility of a remote study design for longitudinal research. We also find that study topic, flexibility of study, and positive interactions with the study team are important factors for participant recruitment and retention. This work suggests that the increased flexibility of a fully remote design enables engagement of individuals who may otherwise be excluded from clinical research.